DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION

Jenoptik AG

XTRA:JEN Voorraadrapport

Marktkapitalisatie: €2.1b

  • Bedrijfsoverzicht
    • Waardering
    • Toekomstige groei
    • Prestaties in het verleden
    • Financiële gezondheid
    • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

Jenoptik Toekomstige groei

Future criteriumcontroles 4/6

Jenoptik zal naar verwachting groeien in winst en omzet met respectievelijk 20.3% en 8.7% per jaar. De winst per aandeel zal naar verwachting groeien met 20.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13% zijn.

Belangrijke informatie

20.3%

Groei van de winst

20.29%

Groei van de winst per aandeel

Electronic winstgroei32.3%
Inkomstengroei8.7%
Toekomstig rendement op eigen vermogen13.01%
Dekking van analisten

Good

Laatst bijgewerkt10 Sep 2026

Recente toekomstige groei-updates

Analyse-artikel • Aug 15

Analysts Have Made A Financial Statement On Jenoptik AG's (ETR:JEN) Second-Quarter Report

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...
Analyse-artikel • May 16

Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...

Recent updates

User avatar
Narratiefupdate • Sep 03

JEN: Future Returns Will Hinge On Semiconductor Demand And Execution Risks

Jenoptik's analyst fair value has moved from €29.50 to €37.00 as analysts point to higher price targets, supported by recent research citing stronger semiconductor demand indicators and solid order intake trends. Analyst Commentary Recent research coverage on Jenoptik has focused on higher price targets and the role of semiconductor demand indicators.
Analyse-artikel • Aug 15

Analysts Have Made A Financial Statement On Jenoptik AG's (ETR:JEN) Second-Quarter Report

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...
User avatar
Narratiefupdate • Aug 13

JEN: Semiconductor Demand And Order Visibility Will Shape Future P/E Expectations

The analyst price target for Jenoptik has been revised from €43.44 to €45.31. Analysts attribute this change to recent price target increases from Jefferies and Deutsche Bank, which cite stronger semiconductor demand and solid Q1 order intake as key factors supporting the adjustment.
User avatar
Narratiefupdate • Jul 07

JEN: Mixed Broker Views And P/E Assumptions Will Shape Fair Value

The analyst price target for Jenoptik has increased from €38.31 to €43.44. Analysts attribute this change to updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E, as well as recent mixed broker commentary, which includes a higher €44 target from one firm and a downgrade from another.
User avatar
Narratiefupdate • Jun 22

JEN: Rising P/E Confidence Will Support Appeal As Execution Strengthens

The analyst fair value estimate for Jenoptik has been raised from €33 to €55, reflecting higher price targets from several firms and analyst expectations for stronger revenue growth, profit margins and P/E assumptions. Analyst Commentary Recent research on Jenoptik points to a cluster of more optimistic views, with several bullish analysts lifting price targets and, in some cases, upgrading their stance on the stock.
User avatar
Narratiefupdate • Jun 08

JEN: Future Returns Will Rely On Delivering Against Richer P E Expectations

Analysts have lifted the Jenoptik fair value estimate from €24.00 to €29.50, reflecting higher published price targets from several banks and updated assumptions for growth, profitability and future P/E. Analyst Commentary Street research on Jenoptik is mixed, with some firms lifting price targets and others turning more cautious on the stock.
User avatar
Narratiefupdate • May 25

JEN: Future P/E Repricing Will Pressure Fair Value Despite Recent Optimism

The analyst price target for Jenoptik has been raised from about €34.81 to about €38.31. Analysts point to refreshed views on growth, margins, and a higher assumed future P/E multiple, following several recent target increases and rating changes on the stock.
User avatar
Narratiefupdate • May 06

JEN: Fair Value View Will Hinge On Mixed P/E And Margin Expectations

Analysts have raised the fair value estimate for Jenoptik from €28.50 to approximately €34.81, reflecting updated assumptions on revenue growth, profit margins, and future P/E, along with recent mixed rating and price target revisions from several banks. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets for Jenoptik, which points to greater confidence in the company’s ability to support a higher fair value over time if it executes as expected.
User avatar
Narratiefupdate • Apr 21

JEN: Future Returns Will Depend On Execution Against Higher P E Assumptions

Analysts have raised their price targets on Jenoptik by €1 to €6, citing slightly adjusted assumptions for revenue growth, profit margins and future P/E multiples as the key factors behind the revised estimates. Analyst Commentary Recent research updates on Jenoptik point to a mixed backdrop, with higher price targets and rating upgrades sitting alongside more cautious voices that are focused on execution risk and valuation sensitivity.
User avatar
Narratiefupdate • Apr 06

JEN: Future Returns Will Depend On Cautious P/E Assumptions Despite Recent Upgrade

Analysts have nudged their Jenoptik price targets higher, with recent increases of €1 and €6. These changes help to support a slightly lower P/E assumption and a modestly stronger revenue growth outlook in the updated model.
User avatar
Narratiefupdate • Mar 23

JEN: Higher P/E Confidence Will Support Appeal Despite Margin Reset

Analysts have raised their fair value estimate for Jenoptik from €32.00 to €33.00, reflecting updated assumptions on revenue growth, profit margins, and future P/E, as well as recent supportive Street research. Analyst Commentary Recent Street research points to a more constructive tone around Jenoptik, with bullish analysts highlighting factors they see as supportive of the revised €33.00 fair value estimate.
User avatar
Narratiefupdate • Mar 09

JEN: Fair Value View Will Rely On Margins And P/E Holding Firm

Analysts have raised their price target on Jenoptik from €25.56 to €28.50. They cite adjustments to fair value estimates, discount rate assumptions, revenue growth expectations, profit margin outlook and future P/E levels as the reasons for the change.
User avatar
Narratiefupdate • Feb 23

JEN: Future Returns Will Depend On Uncertain Margin And P/E Assumptions

Narrative Update on Jenoptik Analysts have lifted their fair value estimate for Jenoptik from €21.50 to €24.00. This reflects slightly adjusted assumptions around discount rates, revenue growth, profit margins and future P/E multiples in recent research updates.
Analyse-artikel • Feb 14

We Think Jenoptik (ETR:JEN) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
User avatar
Narratiefupdate • Feb 09

JEN: Upgraded Outlook Will Rely On Optimistic Margin And P/E Assumptions

Analysts have nudged their fair value target for Jenoptik slightly higher to €21.50, citing updated assumptions for discount rate, revenue growth, profit margin and future P/E that reflect the latest Deutsche Bank research upgrade and related Street analysis. Analyst Commentary Recent research points to a more cautious tone around Jenoptik, even with fair value estimates now centered around €21.50.
Analyse-artikel • Jan 29

Investors Appear Satisfied With Jenoptik AG's (ETR:JEN) Prospects As Shares Rocket 25%

Jenoptik AG ( ETR:JEN ) shareholders have had their patience rewarded with a 25% share price jump in the last month...
User avatar
Narratiefupdate • Jan 26

JEN: Multi Year Outlook Will Balance Leadership Transition And Earnings Multiple

Analysts have reaffirmed their price target on Jenoptik at €21.50, reflecting updated views on the company’s discount rate, revenue growth assumptions, profit margin outlook, and expected future P/E multiple. What's in the News Jenoptik's supervisory board announced that President & CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, after nearly nine years in the role, and will leave Jenoptik AG by mutual agreement.
User avatar
Narratiefupdate • Jan 11

JEN: Higher Margin Outlook Will Support Appeal Despite Leadership Transition

Analysts have trimmed their fair value estimate for Jenoptik from €34.22 to €32.00, citing updated assumptions for slightly lower revenue growth, a higher profit margin and a reduced future P/E multiple. What's in the News The supervisory board announced that Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026 and leave Jenoptik AG by mutual agreement after nearly nine years as President & CEO (Key Developments).
Analyse-artikel • Jan 03

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Jenoptik AG ( ETR:JEN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...
User avatar
Narratiefupdate • Dec 26

JEN: Multi Year Revenue Outlook Will Support Stronger Future Earnings Multiple

Analysts have raised their price target on Jenoptik from €18.50 to €21.50, reflecting improved expectations for multi year revenue growth, slightly higher profit margins, and a richer future earnings multiple. What's in the News The supervisory board announced that President and CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, and will leave Jenoptik AG by mutual agreement after nearly nine years in the role (company announcement) Valuation Changes The fair value estimate has risen moderately from €18.50 to €21.50, reflecting a more optimistic outlook on Jenoptik's intrinsic worth.
User avatar
Narratiefupdate • Dec 12

JEN: Stable Margins And Leadership Transition Will Support Future Upside Potential

Analysts have marginally increased their price target on Jenoptik to approximately $25.56. This reflects slightly higher assumptions for the company’s discount rate and future price to earnings multiple, while maintaining stable growth and margin expectations.
Analyse-artikel • Dec 01

An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €39.06 Jenoptik's €19.74 share...
User avatar
Narratiefupdate • Nov 27

JEN: Modest Profit Margin Increase Will Drive Upside Potential

Analysts have raised their price target on Jenoptik slightly, increasing it from €25.44 to €25.56. They cited refinements in their financial models based on modest improvements in the company’s valuation metrics and outlook.
User avatar
Narratiefupdate • Nov 13

JEN: Revenue Gains And Profit Margin Improvement Will Support Upside Potential

Analysts have increased their fair value estimate for Jenoptik from €24.46 to €25.44. This change reflects expectations of higher revenue growth and improved profit margins, even though the discount rate is slightly lower.
Analyse-artikel • Oct 04

Cautious Investors Not Rewarding Jenoptik AG's (ETR:JEN) Performance Completely

With a price-to-earnings (or "P/E") ratio of 14.3x Jenoptik AG ( ETR:JEN ) may be sending bullish signals at the...
User avatar
Narratiefupdate • Sep 12

Global Semiconductor Investment Will Advance Photonics And Mobility Expansion

The downward revision in Jenoptik’s consensus price target reflects softer revenue growth forecasts, with fair value decreasing from €25.12 to €24.46. What's in the News Jenoptik AG removed from Germany MDAX Index (Performance).
Analyse-artikel • Aug 30

An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued

Key Insights The projected fair value for Jenoptik is €33.48 based on 2 Stage Free Cash Flow to Equity Jenoptik's...
Analyse-artikel • Jul 23

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyse-artikel • May 16

Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...
Analyse-artikel • Apr 30

Jenoptik (ETR:JEN) Is Paying Out A Larger Dividend Than Last Year

Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its dividend from last year's comparable payment on...
Analyse-artikel • Apr 20

Are Investors Undervaluing Jenoptik AG (ETR:JEN) By 34%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €24.74 Jenoptik's €16.45 share...
Analyse-artikel • Apr 05

Benign Growth For Jenoptik AG (ETR:JEN) Underpins Stock's 34% Plummet

Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 34% share...
Analyse-artikel • Feb 27

At €23.20, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Jenoptik AG ( ETR:JEN ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
User avatar
Nieuw narratief • Feb 22

Investments In Dresden Facility And Diversification Will Support Future Performance

Strategic investments in semiconductor capacity and sales channels bolster future growth, helping offset market volatility and enhance revenue potential.
Analyse-artikel • Jan 13

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel • Nov 15

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jenoptik AG ( ETR:JEN ) shareholders are probably feeling a little disappointed, since its shares fell 3.2% to €21.82...
Analyse-artikel • Nov 14

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 28% share...
Analyse-artikel • Oct 14

Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Key Insights The projected fair value for Jenoptik is €54.80 based on 2 Stage Free Cash Flow to Equity Current share...
Analyse-artikel • Sep 28

Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...
Analyse-artikel • Aug 15

Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Analyse-artikel • Jun 12

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Key Insights Jenoptik will host its Annual General Meeting on 18th of June CEO Stefan Traeger's total compensation...
Analyse-artikel • May 30

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analyse-artikel • Apr 25

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

The board of Jenoptik AG ( ETR:JEN ) has announced that it will be paying its dividend of €0.35 on the 21st of June, an...
Analyse-artikel • Apr 15

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Analyse-artikel • Mar 30

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its periodic dividend on the 21st of June to €0.35...
Analyse-artikel • Mar 22

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...
Analyse-artikel • Jan 07

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 16x, you may consider...
Analyse-artikel • Dec 20

Is Jenoptik (ETR:JEN) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel • Dec 05

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

While Jenoptik AG ( ETR:JEN ) might not be the most widely known stock at the moment, it saw a significant share price...

Winst- en omzetgroeiprognoses

XTRA:JEN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20281,3391541292099
12/31/20271,2471331091879
12/31/20261,1341041001758
6/30/20261,05187133189N/A
3/31/20261,04476114174N/A
12/31/20251,04669123196N/A
9/30/20251,0546892176N/A
6/30/20251,0737369164N/A
3/31/20251,1038580180N/A
12/31/20241,1169174167N/A
9/30/20241,11284100190N/A
6/30/20241,10280102184N/A
3/31/20241,0887669155N/A
12/31/20231,0667379167N/A
9/30/20231,0517072154N/A
6/30/20231,0386869152N/A
3/31/20231,0067087170N/A
12/31/20229816263143N/A
9/30/20229297556130N/A
6/30/20228698148113N/A
3/31/2022809913892N/A
12/31/2021751915298N/A
9/30/20216306956101N/A
6/30/2021616584789N/A
3/31/2021602374887N/A
12/31/2020615334690N/A
9/30/20207654869113N/A
6/30/20208015494143N/A
3/31/202083657N/A136N/A
12/31/201985568N/A109N/A
9/30/201983778N/A90N/A
6/30/201983378N/A91N/A
3/31/201982982N/A118N/A
12/31/201883588N/A135N/A
9/30/201881482N/A119N/A
6/30/201878483N/A97N/A
3/31/201877480N/A95N/A
12/31/201774873N/A96N/A
9/30/201771962N/A94N/A
6/30/201770655N/A107N/A
3/31/201769056N/A103N/A
12/31/201668554N/A100N/A
9/30/201667451N/A108N/A
6/30/201667951N/A102N/A
3/31/201668148N/A101N/A
12/31/201566949N/A85N/A
9/30/201565846N/A69N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei JEN ( 20.3% per jaar) ligt boven de spaarquote ( 2.1% ).

Winst versus markt: De winst van JEN ( 20.3% per jaar) zal naar verwachting sneller groeien dan de German markt ( 15% per jaar).

Hoge groeiwinsten: De winst van JEN zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van JEN ( 8.7% per jaar) zal naar verwachting sneller groeien dan de markt German ( 6.6% per jaar).

Hoge groei-inkomsten: De omzet van JEN ( 8.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen JEN zal naar verwachting over 3 jaar laag zijn ( 13 %).


Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/15 09:22
Aandelenkoers aan het einde van de dag2026/09/15 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Jenoptik AG wordt gevolgd door 18 analisten. 9 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Peter RothenaicherBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Lasse StuebenBerenberg

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten